Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240208060940N1Phase 3Completed
Phase 3, randomised, double-blind trial in None comparing Etomidate with Propofol (2 arms). Primary endpoints: Proceduralist satisfaction, Patient satisfaction and 3 more. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240208060940N1.